Recommended Duration of Ceftriaxone for Bacillary Dysentery in Pediatrics
For pediatric patients with bacillary dysentery (shigellosis), ceftriaxone should be administered intravenously at 50-80 mg/kg once daily for 3 days. 1
Dosing and Duration
The WHO Pocket Book of Hospital Care for Children provides clear guidance for dysentery treatment in children:
- Dose: 50-80 mg/kg IV once daily
- Duration: 3 days
- Route: Intravenous administration
- Position in therapy: Second-line agent (first-line is oral ciprofloxacin 15 mg/kg twice daily for 3 days) 1
Clinical Context and Rationale
Ceftriaxone is recommended as second-line therapy when:
- Oral ciprofloxacin cannot be used or has failed
- The child has severe illness requiring parenteral therapy
- Local resistance patterns favor cephalosporin use over fluoroquinolones
The 3-day duration is specifically evidence-based for dysentery and should not be extended without clear clinical indication. This short course balances antimicrobial stewardship with clinical efficacy 1.
Important Caveats
Age-Specific Considerations
For neonates and young infants, dosing differs:
- Neonates ≤7 days: 50 mg/kg once daily
- Neonates >7 days and ≤2000g: 50 mg/kg once daily
- Neonates >7 days and >2000g: 50-75 mg/kg once daily 2
Administration Details
- Infusion time: Administer over 60 minutes in neonates to reduce risk of bilirubin encephalopathy 3
- Maximum dose: Should not exceed 4 grams daily in older children 4
- Contraindication: Do not use in hyperbilirubinemic neonates or premature infants 2, 4
Antimicrobial Resistance Considerations
The choice between ciprofloxacin and ceftriaxone should be guided by local susceptibility patterns. Recent evidence shows:
- Ciprofloxacin resistance in Shigella is increasing globally, particularly in Asia-Africa regions 5
- Azithromycin and cefixime are emerging as oral alternatives when ciprofloxacin resistance is high 5
- Third-generation cephalosporin resistance remains relatively low (2.5% in Asia-Africa) but is increasing 5
Do not extend therapy beyond 3 days unless there is documented bacteremia, extraintestinal complications, or failure to respond clinically. Prolonged antibiotic courses do not improve outcomes in uncomplicated dysentery and may promote resistance 1.